Pharmacokinetics (PK) and Safety Study of XARTEMIS® XR in Postsurgical Adolescent Subjects With Moderate to Severe Acute Pain
Clinical trial NCT02508935 · TERMINATED
Trial details
- NCT number
- NCT02508935
- Sponsor
- Mallinckrodt
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-20
- Primary completion
- 2017-04-26
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.